AGT-190

N/A

Report date: 2023/01/14 15:50:55

Base Information

Drug NameAGT-190
Drug Alias NameAGT-190
ClassificationBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionGlial cell line-derived neurotrophic factor receptors agonists
TargetsGlial cell line-derived neurotrophic factor receptors
Therapy Area/IndicationsStrokeParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArmagen Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesArmagen Technologies Inc
Inactive CompaniesN/A
Active IndicationsStrokeParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A